
BMS exits Cellares deal as cell-therapy maker restructures
Bristol Myers Squibb has terminated its partnership with Cellares, the cell-therapy manufacturing company, prompting Cellares to reorganize its operations after a comprehensive evaluation.
All articles tagged with #cellares

Bristol Myers Squibb has terminated its partnership with Cellares, the cell-therapy manufacturing company, prompting Cellares to reorganize its operations after a comprehensive evaluation.

Cellares has expanded its partnership deal with Bristol Myers Squibb to assist in developing another CAR-T cell therapy using its cell therapy manufacturing platform, Cell Shuttle. The company is also planning for long-term expansion, including new collaborations and builds in the US, Europe, and Asia, as there has been significant interest from pharmaceutical companies looking to partner.